| Literature DB >> 27436875 |
Ester Perales-Clemente1, Alexandra N Cook2, Jared M Evans3, Samantha Roellinger4, Frank Secreto2, Valentina Emmanuele5, Devin Oglesbee4, Vamsi K Mootha6, Michio Hirano7, Eric A Schon8, Andre Terzic1, Timothy J Nelson9.
Abstract
Functional variability among human clones of induced pluripotent stem cells (hiPSCs) remains a limitation in assembling high-quality biorepositories. Beyond inter-person variability, the root cause of intra-person variability remains unknown. Mitochondria guide the required transition from oxidative to glycolytic metabolism in nuclear reprogramming. Moreover, mitochondria have their own genome (mitochondrial DNA [mtDNA]). Herein, we performed mtDNA next-generation sequencing (NGS) on 84 hiPSC clones derived from a cohort of 19 individuals, including mitochondrial and non-mitochondrial patients. The analysis of mtDNA variants showed that low levels of potentially pathogenic mutations in the original fibroblasts are revealed through nuclear reprogramming, generating mutant hiPSCs with a detrimental effect in their differentiated progeny. Specifically, hiPSC-derived cardiomyocytes with expanded mtDNA mutations non-related with any described human disease, showed impaired mitochondrial respiration, being a potential cause of intra-person hiPSC variability. We propose mtDNA NGS as a new selection criterion to ensure hiPSC quality for drug discovery and regenerative medicine.Entities:
Keywords: global private mutation; human iPSC; intra‐person variability; mitochondrial DNA; quality control; universal heteroplasmy
Mesh:
Substances:
Year: 2016 PMID: 27436875 PMCID: PMC5282833 DOI: 10.15252/embj.201694892
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598